EA200001104A1 - Аскорбат пароксетина - Google Patents
Аскорбат пароксетинаInfo
- Publication number
- EA200001104A1 EA200001104A1 EA200001104A EA200001104A EA200001104A1 EA 200001104 A1 EA200001104 A1 EA 200001104A1 EA 200001104 A EA200001104 A EA 200001104A EA 200001104 A EA200001104 A EA 200001104A EA 200001104 A1 EA200001104 A1 EA 200001104A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- paroxetine
- ascorbat
- published
- useful
- international
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808896.6A GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
| PCT/GB1999/001244 WO1999055698A1 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200001104A1 true EA200001104A1 (ru) | 2001-04-23 |
Family
ID=10831008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200001104A EA200001104A1 (ru) | 1998-04-25 | 1999-04-23 | Аскорбат пароксетина |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1089995A1 (hu) |
| JP (1) | JP2002513019A (hu) |
| KR (1) | KR20010042977A (hu) |
| CN (1) | CN1297448A (hu) |
| AP (1) | AP2000001963A0 (hu) |
| AU (1) | AU3618499A (hu) |
| BG (1) | BG104940A (hu) |
| BR (1) | BR9909868A (hu) |
| CA (1) | CA2330055A1 (hu) |
| EA (1) | EA200001104A1 (hu) |
| GB (1) | GB9808896D0 (hu) |
| HU (1) | HUP0102116A3 (hu) |
| ID (2) | ID26654A (hu) |
| IL (1) | IL139081A0 (hu) |
| NO (1) | NO20005352D0 (hu) |
| PL (1) | PL343677A1 (hu) |
| SK (1) | SK15912000A3 (hu) |
| TR (1) | TR200003084T2 (hu) |
| WO (1) | WO1999055698A1 (hu) |
| ZA (1) | ZA200005912B (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
| CA2471144C (en) | 2002-01-09 | 2011-06-07 | Emisphere Technologies, Inc. | Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
| CN110607553B (zh) * | 2018-10-30 | 2024-03-22 | 中国科学院化学研究所 | 一种制备粒径可调的药物或药物中间体单晶或无定型物的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
| US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
| ES2117557B1 (es) * | 1996-02-29 | 1999-07-01 | Ferrer Int | Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina. |
-
1998
- 1998-04-25 GB GBGB9808896.6A patent/GB9808896D0/en not_active Ceased
-
1999
- 1999-04-23 CA CA002330055A patent/CA2330055A1/en not_active Abandoned
- 1999-04-23 AP APAP/P/2000/001963A patent/AP2000001963A0/en unknown
- 1999-04-23 ID IDW20002169A patent/ID26654A/id unknown
- 1999-04-23 JP JP2000545858A patent/JP2002513019A/ja active Pending
- 1999-04-23 EP EP99918151A patent/EP1089995A1/en not_active Withdrawn
- 1999-04-23 KR KR1020007011809A patent/KR20010042977A/ko not_active Application Discontinuation
- 1999-04-23 HU HU0102116A patent/HUP0102116A3/hu unknown
- 1999-04-23 ID IDW20002168A patent/ID26083A/id unknown
- 1999-04-23 BR BR9909868-7A patent/BR9909868A/pt not_active Application Discontinuation
- 1999-04-23 PL PL99343677A patent/PL343677A1/xx not_active Application Discontinuation
- 1999-04-23 EA EA200001104A patent/EA200001104A1/ru unknown
- 1999-04-23 AU AU36184/99A patent/AU3618499A/en not_active Abandoned
- 1999-04-23 SK SK1591-2000A patent/SK15912000A3/sk unknown
- 1999-04-23 TR TR2000/03084T patent/TR200003084T2/xx unknown
- 1999-04-23 IL IL13908199A patent/IL139081A0/xx unknown
- 1999-04-23 WO PCT/GB1999/001244 patent/WO1999055698A1/en not_active Application Discontinuation
- 1999-04-23 CN CN99805160A patent/CN1297448A/zh active Pending
-
2000
- 2000-10-23 ZA ZA200005912A patent/ZA200005912B/en unknown
- 2000-10-24 NO NO20005352A patent/NO20005352D0/no not_active Application Discontinuation
- 2000-11-13 BG BG104940A patent/BG104940A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999055698A1 (en) | 1999-11-04 |
| HUP0102116A3 (en) | 2002-12-28 |
| PL343677A1 (en) | 2001-08-27 |
| SK15912000A3 (sk) | 2001-04-09 |
| GB9808896D0 (en) | 1998-06-24 |
| JP2002513019A (ja) | 2002-05-08 |
| EP1089995A1 (en) | 2001-04-11 |
| IL139081A0 (en) | 2001-11-25 |
| ID26083A (id) | 2000-11-23 |
| HUP0102116A2 (hu) | 2002-05-29 |
| ZA200005912B (en) | 2001-12-19 |
| TR200003084T2 (tr) | 2001-02-21 |
| CN1297448A (zh) | 2001-05-30 |
| NO20005352L (no) | 2000-10-24 |
| BG104940A (bg) | 2001-09-28 |
| AU3618499A (en) | 1999-11-16 |
| NO20005352D0 (no) | 2000-10-24 |
| BR9909868A (pt) | 2000-12-19 |
| KR20010042977A (ko) | 2001-05-25 |
| AP2000001963A0 (en) | 2000-12-31 |
| CA2330055A1 (en) | 1999-11-04 |
| ID26654A (id) | 2001-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199800667A1 (ru) | Новые фенантридины | |
| CO4970820A1 (es) | Sal de bisulfato del inhibidor de la vih-proteasa | |
| ATE297898T1 (de) | 4-carboxamino-2-subsitutierte-1,2,3,4- tetrahydrochinoline als cetp inhibitoren | |
| ATE277906T1 (de) | 4-carboxamino-2-methyl-1,2,3,4- tetrahydrochinoline als cetp inhibitoren | |
| ES2182234T3 (es) | Inhibidores de metaloproteasa. | |
| ATE226201T1 (de) | Substituierte pyridylpyrazole | |
| ATE268324T1 (de) | 4-amino substituierte -2-subsituierte-1,2,3,4- tetrahydrochinoline als cetp inhibitoren | |
| EA200000098A1 (ru) | 4-АМИНОПИРРОЛ(3,2-d)ПИРИМИДИНЫ В КАЧЕСТВЕ АНТАГОНИСТОВ РЕЦЕПТОРА НЕЙРОПЕПТИДА Y | |
| DE69706019D1 (de) | Selbsteinstellende, schwingungsdämpfende Vorrichtung | |
| EA199900758A1 (ru) | Малые молекулы, полезные при лечении воспалительных заболеваний | |
| EA199900620A1 (ru) | Фталазиноны | |
| YU48698A (sh) | Karboksamidni derivati pirolidina, piperidina i heksahidroazepina za lečenje oboljenja na bazi tromboze | |
| EA200100854A1 (ru) | Кальций-литические соединения | |
| EA200100517A1 (ru) | Антагонисты 5ht1 для антидепрессантной терапии | |
| AR022321A1 (es) | Derivados de anticonvulsivo utiles para el tratamiento de la migrana transformada | |
| EA200000628A1 (ru) | Ингибиторы металлопротеаз матрикса | |
| EA200000561A1 (ru) | Триазиновые соединения для лечения расстройств цнс | |
| EA200001104A1 (ru) | Аскорбат пароксетина | |
| ATE251457T1 (de) | Substituierte 1,2,3,4-tetrahydro-2- dibenzofuranamine und 2- aminocyclohepta(b)benzofurane | |
| EA200200798A1 (ru) | Кальцилитические соединения | |
| EA200100182A1 (ru) | Лечение состояний тревожности | |
| EA200500878A1 (ru) | Кальцилитические соединения | |
| EA200001105A1 (ru) | 10-камфорсульфонат пароксетина для лечения нарушений цнс | |
| EA200001153A1 (ru) | Очистка карбоксальдегида | |
| FI910896A0 (fi) | 6-substituerade hexahydrobens (cd) indoler. |